Colorectal cancer (CRC) is one of the most prevalent types of cancer and has a high mortality rate globally. Oral ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

A study revealed that IBD patients, particularly those with ulcerative colitis and multiple biologic treatments, face an ...

Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

A preliminary modeling study suggests that four variables accessible at discharge could predict the risk for 90-day ...

Qu Biologics has completed four Phase 2 studies in lung cancer, Crohn’s disease, and ulcerative colitis. Two additional Phase 2 randomized placebo-controlled studies, in late-stage colon cancer and ...

To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...